CTA
DRNA

Carillon Tower Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Carillon Tower Advisers’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$24.7M Sell
2020
Q3 		$21.2M Buy
2020
Q2 		$28.5M Hold
2020
Q1 		$19.4M Hold
2019
Q4 		$24.7M Hold
2019
Q3 		$16.1M Buy